First Trust Nasdaq Pharmaceuticals ETF Rating $34.14 +0.17 (+0.50%) As of 03:57 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsTrendsBuy This Stock First Trust Nasdaq Pharmaceuticals ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FTXH Aggregate RatingModerate Buy 2.62Holdings in FTXH have an aggregate rating of Moderate Buy based on 521 analyst ratings issued in the past year covering 25 companies (84.9% of the portfolio).FTXH Aggregate Price Target$34.14High Prediction$34.14Average Prediction$34.14Low Prediction$34.14Holdings in FTXH have an aggregate price target of $34.14 and a range of $34.14 to $34.14 covering 25 companies (84.9% of the portfolio).FTXH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy15 Moderate Buy rating(s)Hold10 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by First Trust Nasdaq Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 FTXH Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings7.18%BMYBristol Myers Squibb$56.94-0.8%4.7086 of 5 stars2.37$61.31 7.7%19Trending NewsEarnings Report6.94%MRKMerck & Co., Inc.$113.21+0.1%4.8152 of 5 stars2.68$128.18 13.2%19Trending NewsEarnings Report6.93%JNJJohnson & Johnson$225.59+0.6%4.921 of 5 stars2.67$252.48 11.9%27Trending News6.67%LLYEli Lilly and Company$989.02+2.2%4.8771 of 5 stars2.87$1,217.59 23.1%30Trending NewsEarnings ReportDividend AnnouncementAnalyst Upgrade6.58%ABBVAbbVie$206.12-1.0%4.9083 of 5 stars2.85$252.90 22.7%26Trending NewsEarnings Report3.77%BIIBBiogen$189.13+1.0%4.0892 of 5 stars2.50$214.23 13.3%28Earnings ReportAnalyst Upgrade3.70%VTRSViatris$15.53+2.2%1.4407 of 5 stars2.43$14.67 -5.6%7News CoverageUpcoming EarningsDividend AnnouncementGap Down3.69%PFEPfizer$26.42+0.5%3.9753 of 5 stars2.23$28.74 8.8%22Trending NewsEarnings Report3.64%REGNRegeneron Pharmaceuticals$702.45-1.0%4.2943 of 5 stars2.77$826.59 17.7%26Earnings ReportDividend AnnouncementAnalyst Upgrade3.41%ZTSZoetis$112.60-0.1%4.9545 of 5 stars2.40$151.75 34.8%15Positive NewsUpcoming EarningsAnalyst Downgrade3.40%GILDGilead Sciences$133.48+0.6%4.8337 of 5 stars2.86$157.35 17.9%28Trending NewsUpcoming Earnings3.39%AMGNAmgen$329.59+1.8%4.4701 of 5 stars2.42$357.12 8.4%31Trending NewsEarnings ReportAnalyst Forecast3.35%VRTXVertex Pharmaceuticals$424.36-1.3%4.6035 of 5 stars2.83$554.83 30.7%29Trending NewsEarnings ReportAnalyst DowngradeInsider Trade3.33%CAHCardinal Health$196.970.0%4.8443 of 5 stars2.94$241.80 22.8%18Earnings ReportAnalyst Upgrade3.23%UTHRUnited Therapeutics$572.20-1.6%3.5587 of 5 stars2.77$601.50 5.1%13Upcoming EarningsInsider Trade2.33%JAZZJazz Pharmaceuticals$212.26+2.0%3.4469 of 5 stars2.83$216.87 2.2%18News CoveragePositive NewsEarnings Report2.28%INCYIncyte$97.47+0.3%4.0758 of 5 stars2.43$104.26 7.0%21Earnings ReportAnalyst Forecast1.66%EXELExelixis$44.42+0.6%3.3604 of 5 stars2.39$47.00 5.8%23Trending NewsEarnings Report1.64%ILMNIllumina$139.07-0.2%3.065 of 5 stars2.22$131.06 -5.8%18Earnings ReportAnalyst Forecast1.52%MEDPMedpace$430.32+3.2%3.0638 of 5 stars2.20$467.08 8.5%15Trending NewsGap Down1.35%CRLCharles River Laboratories International$185.27+7.5%2.3125 of 5 stars2.63$205.36 10.8%16News CoverageUpcoming Earnings1.33%PTCTPTC Therapeutics$65.04-0.7%3.8059 of 5 stars2.63$84.40 29.8%16News CoveragePositive NewsUpcoming Earnings1.19%NBIXNeurocrine Biosciences$135.06+0.7%3.81 of 5 stars2.82$180.45 33.6%22Trending News1.18%HALOHalozyme Therapeutics$65.87+2.0%4.2853 of 5 stars2.42$79.11 20.1%12Upcoming EarningsInsider Trade1.18%BMRNBioMarin Pharmaceutical$53.24-4.0%4.5105 of 5 stars2.77$90.32 69.6%22Trending NewsAnalyst ForecastHigh Trading Volume This page (NASDAQ:FTXH) was last updated on 5/5/2026 by MarketBeat.com Staff. From Our PartnersYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSell 99% of Your Stocks, Do THIS Instead…Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...The Oxford Club | SponsoredTrade this between 9:30 and 10:45 am ESTThe first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...Base Camp Trading | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredElon Unveils AI Passive Income Stream for Millions of AmericansDuring Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...InvestorPlace | SponsoredInvest in SpaceX Before IPOSpaceX is already one of the most valuable private companies on Earth, and some analysts believe its valuation...NXT Wave Research | SponsoredURGENT: $2 Gold Stock With Major DiscoveryA $2 gold stock is said to quietly control what may be the largest gold deposit in the world - worth nearly $1...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust Nasdaq Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust Nasdaq Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FTXH Stock Alerts